Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing

Since September 2010, over 10,000 patients have undergone preemptive, panel-based pharmacogenomic testing through the Vanderbilt Pharmacogenomic Resource for Enhanced Decisions in Care and Treatment (PREDICT) program. Analysis of the genetic data from the first 9,589 individuals reveals the frequenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Driest, Sara L., Shi, Yaping, Bowton, Erica A., Schildcrout, Jonathan S., Peterson, Josh F., Pulley, Jill, Denny, Josh C., Roden, Dan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961508/
https://www.ncbi.nlm.nih.gov/pubmed/24253661
http://dx.doi.org/10.1038/clpt.2013.229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961508/
https://www.ncbi.nlm.nih.gov/pubmed/24253661
http://dx.doi.org/10.1038/clpt.2013.229

Ejemplares similares